Continuous Versus 1-min Oscillometric Arterial BP Monitoring

February 4, 2024 updated by: Karam Nam, MD, Seoul National University Hospital

Continuous Invasive Versus 1-min Interval Oscillometric Arterial Pressure Monitoring and Hypotension During Induction of Anesthesia: a Bicenter, Randomized, Noninferiority Trial

Hypotension is common during surgery and about one-third of hypotension occur during the period from anesthesia induction to skin incision. Therefore, monitoring blood pressure during this period is crucial.

Two methods are used for measuring blood pressure during surgery: the intermittent measurement method (oscillometric method) and the continuous measurement method (arterial catheterization method). The latter is frequently used in surgical patients who require meticulous hemodynamic management, although there is no clearly defined indication for its use. Despite the benefits of arterial catheterization, it is often delayed after induction of general anesthesia, and blood pressure is monitored intermittently using the oscillometric method.

A recent study showed that continuous arterial pressure monitoring using arterial catheterization method during the induction of general anesthesia reduced hypotension significantly compared to 2.5-min interval intermittent arterial pressure monitoring using oscillometric method. The study was conducted on patients scheduled for continuous arterial pressure monitoring during surgery and the group with continuous arterial pressure monitoring showed significantly lower incidence of hypotension during the first 15 minutes of anesthesia induction.

However, measuring blood pressure using the oscillometric method at 1-min interval, rather than 2.5-min interval, may not be significantly inferior to continuous monitoring via arterial catheterization in terms of hypotension occurrence. This study aims to compare hypotension incidence between arterial catheterization method and oscillometric method with 1-min interval during induction of anesthesia in non-cardiac surgery patients.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

244

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Seoul, Korea, Republic of, 03080
        • Recruiting
        • Seoul National University Hospital
        • Contact:
        • Contact:
      • Seoul, Korea, Republic of
        • Not yet recruiting
        • Korea University Guro Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult patients aged 19 or older undergoing scheduled non-cardiac surgery with general anesthesia and continuous invasive arterial blood pressure monitoring via the radial artery

Exclusion Criteria:

  • Arterial access is clinically necessary before induction of anesthesia (e.g., moderate or higher degree of aortic stenosis, moderate or higher degree of heart failure, coronary artery disease requiring revascularization, intracranial aneurysm with a significant risk of rupture, etc.)
  • Emergency surgery
  • American Society of Anesthesiologists (ASA) physical status 5 or 6
  • Arterial access is required in a different artery other than the radial artery (e.g., the femoral artery)
  • Electrocardiogram other than sinus rhythm
  • Refusal to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1-min interval oscillometric method
1-min interval blood pressure monitoring using oscillometric method during induction of anesthesia

Before induction of anesthesia, 20-gauge catheter is inserted to radial artery after local anesthesia with lidocaine, and continuous blood pressure monitoring is started. Anesthesia is induced using propofol, opioids (fentanyl or remifentanil), and neuromuscular relaxants (rocuronium, cisatracurium, or vecuronium). For maintenance of anesthesia, propofol infusion or inhalation anesthetics (sevoflurane or desflurane) are used.

From the start of anesthesia induction to 15 minutes after, arterial blood pressure is monitored at 1-min interval using oscillometric method. The display of continuous arterial pressure on the anesthesia monitor is turned off during the 15-min study period.

Active Comparator: arterial catheterization method
Continuous blood pressure monitoring through arterial catheter during induction of anesthesia
During the same time window for 1-min interval oscillometric method, arterial blood pressure is monitored using continuous blood pressure monitoring.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MAP integral
Time Frame: From the start of anesthesia induction to 15 minutes after
The area under the mean arterial pressure (MAP) of 65 mmHg calculated using the MAP recorded every second
From the start of anesthesia induction to 15 minutes after

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Area under MAP of 60, 50, 40 mmHg (mmHg∙min)
Time Frame: From the start of anesthesia induction to 15 minutes after
calculated using the MAP recorded every second
From the start of anesthesia induction to 15 minutes after
Duration of MAP <65, <60, <50, <40 mmHg (min)
Time Frame: From the start of anesthesia induction to 15 minutes after
calculated using the MAP recorded every second
From the start of anesthesia induction to 15 minutes after
Exposure to MAP <65, <60, <50, and <40 mmHg (binary)
Time Frame: From the start of anesthesia induction to 15 minutes after
calculated using the MAP recorded every second
From the start of anesthesia induction to 15 minutes after
Exposure to continuous MAP <65, <60, <50, <40 mmHg for 1 minute or longer (binary)
Time Frame: From the start of anesthesia induction to 15 minutes after
calculated using the MAP recorded every second
From the start of anesthesia induction to 15 minutes after
Area above MBP of 100, 110, 120, 140 mmHg (mmHg∙min)
Time Frame: From the start of anesthesia induction to 15 minutes after
calculated using the MAP recorded every second
From the start of anesthesia induction to 15 minutes after
MAP standard deviation (mmHg)
Time Frame: From the start of anesthesia induction to 15 minutes after
calculated using the MAP recorded every second
From the start of anesthesia induction to 15 minutes after
Use of vasopressor (binary)
Time Frame: From the start of anesthesia induction to 15 minutes after
ephedrine, phenylephrine, norepinephrine (binary)
From the start of anesthesia induction to 15 minutes after
Use of vasopressor (dose)
Time Frame: From the start of anesthesia induction to 15 minutes after
ephedrine (mg), phenylephrine (μg/kg), norepinephrine (μg/kg)
From the start of anesthesia induction to 15 minutes after
Crystalloid (ml)
Time Frame: From the start of anesthesia induction to 15 minutes after
Total amount of crystalloid administered
From the start of anesthesia induction to 15 minutes after

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Karam Nam, MD, Seoul National University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 27, 2023

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

March 18, 2023

First Submitted That Met QC Criteria

March 18, 2023

First Posted (Actual)

March 31, 2023

Study Record Updates

Last Update Posted (Actual)

February 6, 2024

Last Update Submitted That Met QC Criteria

February 4, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia, General

Clinical Trials on 1-min interval oscillometric method

3
Subscribe